Erin M. Wessling - Sep 2, 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & Chief Legal Officer
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Sep 2, 2025
Transactions value $
$0
Form type
4
Date filed
9/4/2025, 11:53 AM
Previous filing
Sep 5, 2025
Next filing
Sep 5, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wessling Erin M EVP & Chief Legal Officer 220 VIRGINIA AVENUE, INDIANAPOLIS /s/ Kathleen S. Kiefer, Attorney in fact 2025-09-04 0002084548

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Award $0 +931 +21.95% $0.00 5.17K Sep 2, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +3.54K $0.00 3.54K Sep 2, 2025 Common Stock 3.54K $322.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units. Restrictions lapse as follows: 310 shares each on 9/2/2026 and 9/2/2027, and 311 on 9/2/2028.
F2 The option represents a right to purchase a total of 3,541 shares, and is exercisable in three annual installments, with two installments of 1,180 shares each and one installment of 1,181 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date.